Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Klotz, Rosa [VerfasserIn]   i
 Larmann, Jan [VerfasserIn]   i
 Klose, Christina [VerfasserIn]   i
 Bruckner, Thomas [VerfasserIn]   i
 Benner, Laura [VerfasserIn]   i
 Dörr-Harim, Colette [VerfasserIn]   i
 Tenckhoff, Solveig [VerfasserIn]   i
 Lock, Johan F. [VerfasserIn]   i
 Brede, Elmar-Marc [VerfasserIn]   i
 Salvia, Roberto [VerfasserIn]   i
 Polati, Enrico [VerfasserIn]   i
 Köninger, Jörg [VerfasserIn]   i
 Schiff, Jan-Henrik [VerfasserIn]   i
 Wittel, Uwe A. [VerfasserIn]   i
 Hötzel, Alexander [VerfasserIn]   i
 Keck, Tobias [VerfasserIn]   i
 Nau, Carla [VerfasserIn]   i
 Amati, Anca-Laura [VerfasserIn]   i
 Koch, Christian [VerfasserIn]   i
 Eberl, Thomas [VerfasserIn]   i
 Zink, Michael [VerfasserIn]   i
 Tomazic, Ales [VerfasserIn]   i
 Novak-Jankovic, Vesna [VerfasserIn]   i
 Hofer, Stefan [VerfasserIn]   i
 Diener, Markus K. [VerfasserIn]   i
 Weigand, Markus A. [VerfasserIn]   i
 Büchler, Markus W. [VerfasserIn]   i
 Knebel, Phillip [VerfasserIn]   i
 Group, for the PAKMAN Trial [VerfasserIn]   i
Titel:Gastrointestinal complications after pancreatoduodenectomy with epidural vs patient-controlled intravenous analgesia
Titelzusatz:a randomized clinical trial
Verf.angabe:Rosa Klotz, Jan Larmann, Christina Klose, Thomas Bruckner, Laura Benner, Colette Doerr-Harim, Solveig Tenckhoff, Johan F. Lock, Elmar-Marc Brede, Roberto Salvia, Enrico Polati, Jörg Köninger, Jan-Henrik Schiff, Uwe A. Wittel, Alexander Hötzel, Tobias Keck, Carla Nau, Anca-Laura Amati, Christian Koch, Thomas Eberl, Michael Zink, Ales Tomazic, Vesna Novak-Jankovic, Stefan Hofer, Markus K. Diener, Markus A. Weigand, Markus W. Büchler, Phillip Knebel; for the PAKMAN Trial Group
E-Jahr:2020
Jahr:May 27, 2020
Umfang:2 S.
Fussnoten:Gesehen am 30.10.2020
Titel Quelle:Enthalten in: JAMA surgery
Ort Quelle:Chicago, Ill. : American Medical Association, 2013
Jahr Quelle:2020
Band/Heft Quelle:155(2020), 7, Seite e200794-e200794
ISSN Quelle:2168-6262
Abstract:<h3>Importance</h3><p>Morbidity is still high in pancreatic surgery, driven mainly by gastrointestinal complications such as pancreatic fistula. Perioperative thoracic epidural analgesia (EDA) and patient-controlled intravenous analgesia (PCIA) are frequently used for pain control after pancreatic surgery. Evidence from a post hoc analysis suggests that PCIA is associated with fewer gastrointestinal complications.</p><h3>Objective</h3><p>To determine whether postoperative PCIA decreases the occurrence of gastrointestinal complications after pancreatic surgery compared with EDA.</p><h3>Design, Setting, and Participants</h3><p>In this adaptive, pragmatic, international, multicenter, superiority randomized clinical trial conducted from June 30, 2015, to October 1, 2017, 371 patients at 9 European pancreatic surgery centers who were scheduled for elective pancreatoduodenectomy were randomized to receive PCIA (n = 185) or EDA (n = 186); 248 patients (124 in each group) were analyzed. Data were analyzed from February 22 to April 25, 2019, using modified intention to treat and per protocol.</p><h3>Interventions</h3><p>Patients in the PCIA group received general anesthesia and postoperative PCIA with intravenous opioids with the help of a patient-controlled analgesia device. In the EDA group, patients received general anesthesia and intraoperative and postoperative EDA.</p><h3>Main Outcomes and Measures</h3><p>The primary end point was a composite of pancreatic fistula, bile leakage, delayed gastric emptying, gastrointestinal bleeding, or postoperative ileus within 30 days after surgery. Secondary end points included 30-day mortality, other complications, postoperative pain levels, intraoperative or postoperative use of vasopressor therapy, and fluid substitution.</p><h3>Results</h3><p>Among the 248 patients analyzed (147 men; mean [SD] age, 64.9 [10.7] years), the primary composite end point did not differ between the PCIA group (61 [49.2%]) and EDA group (57 [46.0%]) (odds ratio, 1.17; 95% CI, 0.71-1.95<i>P</i> = .54). Neither individual components of the primary end point nor 30-day mortality, postoperative pain levels, or intraoperative and postoperative substitution of fluids differed significantly between groups. Patients receiving EDA gained more weight by postoperative day 4 than patients receiving PCIA (mean [SD], 4.6 [3.8] vs 3.4 [3.6] kg;<i>P</i> = .03) and received more vasopressors (46 [37.1%] vs 31 [25.0%];<i>P</i> = .04). Failure of EDA occurred in 23 patients (18.5%).</p><h3>Conclusions and Relevance</h3><p>This study found that the choice between PCIA and EDA for pain control after pancreatic surgery should not be based on concerns regarding gastrointestinal complications because the 2 procedures are comparable with regard to effectiveness and safety. However, EDA was associated with several shortcomings.</p><h3>Trial Registration</h3><p>German Clinical Trials Register:DRKS00007784</p>
DOI:doi:10.1001/jamasurg.2020.0794
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1001/jamasurg.2020.0794
 Volltext: https://jamanetwork.com/journals/jamasurgery/fullarticle/2765992
 DOI: https://doi.org/10.1001/jamasurg.2020.0794
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1737479826
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68655685   QR-Code
zum Seitenanfang